A new study reported by ScienceDaily suggests that oxalate, a naturally occurring compound found in many otherwise healthy foods, may aggravate intestinal inflammation in people with inflammatory bowel disease (IBD). Researchers point to a potential role for gut bacteria in breaking down oxalate before it can trigger this effect, opening a possible new avenue for microbiome-targeted approaches to managing Crohn’s disease and ulcerative colitis.
Oxalate is present in numerous plant foods commonly recommended as part of a balanced diet, including spinach, rhubarb, nuts and certain wholegrains. It is more widely known for its role in kidney stone formation, but its relationship with gut health has received less attention. IBD, encompassing Crohn’s disease and ulcerative colitis, is a chronic condition marked by relapsing gastrointestinal inflammation, and diet is an area of ongoing interest for both patients and clinicians seeking to understand what might worsen or ease symptoms alongside standard medical therapy.
According to the reporting, the study found that dietary oxalate may disrupt the balance of the gut environment in ways that promote intestinal inflammation in people with IBD. The researchers highlighted the gut microbiome as a potential mitigating factor, noting that certain intestinal bacteria, including Oxalobacter formigenes, are capable of breaking down oxalate before it causes harm. This raises the possibility that the presence or absence of specific bacterial species could influence how much oxalate affects gut inflammation in any individual. The findings were framed as pointing towards future microbiome-targeted therapies, potentially involving the restoration or supplementation of oxalate-degrading bacteria as a complementary strategy alongside existing IBD treatments.
For clinicians and dietitians supporting people with IBD, this research adds to a growing body of evidence examining how specific dietary components interact with gut bacteria to influence inflammation, rather than treating diet as a uniform risk factor. If confirmed and expanded through further research, the link between oxalate, gut bacteria and inflammation could eventually inform more individualised dietary guidance for patients with Crohn’s disease or ulcerative colitis. It also underscores the broader relevance of the gut microbiome as a target for future therapies, complementing rather than replacing established pharmacological approaches. Patients should not interpret these findings as a reason to avoid oxalate-containing foods without professional advice, since many of these foods also provide valuable nutrients.
Practical Takeaways
- Oxalate, found in foods such as spinach, rhubarb and nuts, may interact with gut bacteria to influence intestinal inflammation in IBD, according to the reported findings.
- Oxalate-degrading bacteria, including Oxalobacter formigenes, may help protect against this effect, suggesting a possible future role for microbiome-based interventions.
- Any dietary changes related to oxalate intake should be discussed with a gastroenterologist or dietitian, given the nutritional value of many oxalate-containing foods.
Reference
The material supplied for this article originates from a ScienceDaily report (“A hidden compound in healthy foods may worsen IBD”, published September 2026) and a secondary report from SSBCrack News summarising the same underlying research. Neither source identifies the originating journal, authors, or study details with sufficient clarity to trace the primary peer-reviewed publication. In line with source verification standards, no full citation is provided here, as the primary source could not be confirmed from the material available.
This article is a journalistic summary for informational purposes only. It does not constitute clinical advice or a recommendation to alter treatment decisions.